6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
|
|
- CAS-Nr.
- 1812890-23-5
- Englisch Name:
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Synonyma:
- Tofatinib Impurity 17;Tofacitinib Related Compound 23;Azilsartan medoxomil impurity319;Tofacitinib Hydrogenation Impurities;(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine;6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine;5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
- CBNumber:
- CB53143734
- Summenformel:
- C13H21N5
- Molgewicht:
- 247.34
- MOL-Datei:
- 1812890-23-5.mol
|
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Eigenschaften
- Siedepunkt:
- 435.9±45.0 °C(Predicted)
- Dichte
- 1.137±0.06 g/cm3(Predicted)
- L?slichkeit
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- pka
- 9.48±0.10(Predicted)
- Farbe
- Off-White to Pale Yellow
Sicherheit
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine is an intermediate (reagent) in the preparation of Tofacitinib analog compounds.
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 38)Lieferanten
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Related Compound 23
- 5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
- Azilsartan medoxomil impurity319
- Tofacitinib Hydrogenation Impurities
- (6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine
- Tofatinib Impurity 17
- N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
- 1812890-23-5